Technical Analysis for MBRX - Moleculin Biotech, Inc.

Grade Last Price % Change Price Change
grade C 1.13 -2.59% -0.03
MBRX closed down 2.59 percent on Monday, May 20, 2019, on 14 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: May 21

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical MBRX trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -2.59%
Wide Bands Range Expansion -2.59%
Oversold Stochastic Weakness -2.59%
Fell Below 50 DMA Bearish -5.04%
MACD Bearish Centerline Cross Bearish -5.04%

Older signals for MBRX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Moleculin Biotech, Inc., a preclinical and clinical-stage pharmaceutical company, focuses on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia. The company also develops other drugs, including WP1066 Portfolio, a portfolio of small molecules targeting the modulation of transcription factors involved in cancer; and WP1122 Portfolio, a suite of molecules targeting the metabolic processes involved in cancer and glioblastoma. Moleculin Biotech, Inc. was founded in 2015 and is headquartered in Houston, Texas.
Medicine Cancer Pharmaceutical Oncology Chemotherapy Acute Myeloid Leukemia Antineoplastic Drugs Glioblastoma Refractory Acute Myeloid Leukemia
Is MBRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.15
52 Week Low 0.7772
Average Volume 4,539,914
200-Day Moving Average 1.3595
50-Day Moving Average 1.2125
20-Day Moving Average 1.3335
10-Day Moving Average 1.242
Average True Range 0.1679
ADX 43.87
+DI 33.5645
-DI 17.212
Chandelier Exit (Long, 3 ATRs ) 2.6463
Chandelier Exit (Short, 3 ATRs ) 1.5137
Upper Bollinger Band 1.622
Lower Bollinger Band 1.045
Percent B (%b) 0.15
BandWidth 43.269591
MACD Line -0.0232
MACD Signal Line 0.0094
MACD Histogram -0.0326
Fundamentals Value
Market Cap 22.9 Million
Num Shares 20.3 Million
EPS -0.47
Price-to-Earnings (P/E) Ratio -2.40
Price-to-Sales 0.00
Price-to-Book 1.59
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.22
Resistance 3 (R3) 1.22 1.19 1.21
Resistance 2 (R2) 1.19 1.17 1.19 1.20
Resistance 1 (R1) 1.16 1.15 1.16 1.16 1.19
Pivot Point 1.13 1.13 1.13 1.13 1.13
Support 1 (S1) 1.10 1.11 1.10 1.10 1.07
Support 2 (S2) 1.07 1.09 1.07 1.06
Support 3 (S3) 1.04 1.07 1.06
Support 4 (S4) 1.04